Home > Boards > Free Zone > Penny Trading - Technical > BB's Stock Haven

QSAM Fusion Pharmaceuticals, another radiopharmaceutical company in FDA

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
trader_ron Member Profile
Member Level 
Followed By 71
Posts 11,196
Boards Moderated 1
Alias Born 08/05/15
160x600 placeholder
U.S. Ethanol Production Climbs to Highest in Over 3 Years
U.S. ethanol production has risen this week, bringing the daily production rate to its highest in over three years.
Texas Instruments Down Over 5%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Fiserv Down Over 8%, Worst Performer in the S&P 500 and Nasdaq 100 So Far Today -- Data Talk
U.S. Oil Inventories Rise, Fuel Supplies Fall
Carlsberg Lifts Guidance as 3Q Revenue Beat Expectations
Microsoft on Pace for Record High Close -- Data Talk
3Q GDP Seen +2.8% -- Data Week Ahead
Coca-Cola Sees FX Helping This Year, Hurting Next Year -- Currency Comment
Kaival Brands Shares Rise 90% Premarket After FDA Stay of Bidi Vapor Products Denial Order
Monopar Therapeutics Shares Rise 12% Premarket After Patient Dosing
U.K. DMO Cuts Net Financing Requirement, Gilt Remit
Top Company News of the Day
Concerns About High U.S. Inflation May Be Overblown; Hawkish Talk by Two Federal Reserve Governors
GlaxoSmithKline 3Q Net Profit Fell Slightly But Beat Expectations; Raises 2021 Adjusted EPS View -- Update
UK Treasury Chief Sets New Tax, Spending Plans
Norfolk Southern 3Q Earnings Rise
Icahn Launches $75/Share Tender Offer for Southwest Gas
Bio-Path Shares Up Premarket After FDA Trial Clearance
Hertz, Uber Partner to Add Up to 50,000 Teslas to Uber Network by 2023
General Dynamics 3Q Revenue Rises on Higher Aerospace, Marine Sales
Kraft Heinz Raises 2021 Outlook
Novatek 3Q Net Profit Rose Significantly
GlaxoSmithKline 3Q Net Profit Fell Slightly; Raises 2021 Adjusted EPS View
European Companies Anticipate Supply Chain Issues Will Stretch Into 2022
Bristol Myers Squibb Narrows Full-Year Earnings Guidance
trader_ron Member Level  Thursday, 09/16/21 09:20:12 AM
Re: None
Post # of 4842067 
QSAM Fusion Pharmaceuticals, another radiopharmaceutical company in FDA Phase 1, has a market cap of $396.6 million.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences